Miniatura

Fitxers

701172.pdf (1.94 MB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2020-05-16

Llicència de publicació

cc-by (c) Zanieri, Francesca et al., 2020
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/174879

Exogenous Liposomal ceramide-c6 ammeliorates lipidomic profile, energy homeostasis and anti-oxidant systems in NASH

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.3390/cells9051237

Resum

In non-alcoholic steatohepatitis (NASH), many lines of investigation have reported a dysregulation in lipid homeostasis, leading to intrahepatic lipid accumulation. Recently, the role of dysfunctional sphingolipid metabolism has also been proposed. Human and animal models of NASH have been associated with elevated levels of long chain ceramides and pro-apoptotic sphingolipid metabolites, implicated in regulating fatty acid oxidation and inflammation. Importantly, inhibition of de novo ceramide biosynthesis or knock-down of ceramide synthases reverse some of the pathology of NASH. In contrast, cell permeable, short chain ceramides have shown anti-inflammatory actions in multiple models of inflammatory disease. Here, we investigated non-apoptotic doses of a liposome containing short chain C6-Ceramide (Lip-C6) administered to human hepatic stellate cells (hHSC), a key effector of hepatic fibrogenesis, and an animal model characterized by inflammation and elevated liver fat content. On the basis of the results from unbiased liver transcriptomic studies from non-alcoholic fatty liver disease patients, we chose to focus on adenosine monophosphate activated kinase (AMPK) and nuclear factor-erythroid 2-related factor (Nrf2) signaling pathways, which showed an abnormal profile. Lip-C6 administration inhibited hHSC proliferation while improving anti-oxidant protection and energy homeostasis, as indicated by upregulation of Nrf2, activation of AMPK and an increase in ATP. To confirm these in vitro data, we investigated the effect of a single tail-vein injection of Lip-C6 in the methionine-choline deficient (MCD) diet mouse model. Lip-C6, but not control liposomes, upregulated phospho-AMPK, without inducing liver toxicity, apoptosis, or exacerbating inflammatory signaling pathways. Alluding to mechanism, mass spectrometry lipidomics showed that Lip-C6-treatment reversed the imbalance in hepatic phosphatidylcholines and diacylglycerides species induced by the MCD-fed diet. These results reveal that short-term Lip-C6 administration reverses energy/metabolic depletion and increases protective anti-oxidant signaling pathways, possibly by restoring homeostatic lipid function in a model of liver inflammation with fat accumulation.

Matèries

Homeòstasi, Antioxidants, Hepatologia

Matèries (anglès)

Homeostasis, Antioxidants, Hepatology

Citació

Col·leccions

Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Citació

ZANIERI, Francesca, LEVI, Ana, MONTEFUSCO, David, LONGATO, Lisa, DE CHIARA, Francesco, FRENGUELLI, Luca, OMENETTI, Sara, ANDREOLA, Fausto, LUONG, Tu vinh, MASSEY, Veronica, CABALLERIA ROVIRA, Joan, FONDEVILA CAMPO, Constantino, SHANMUGAVELANDY, Sriram s., FOX, Todd, MAZZA, Giuseppe, ARGEMI, Josep maria, BATALLER ALBEROLA, Ramón, COWART, Lauren ashley, KESTER, Mark, PINZANI, Massimo, ROMBOUTS, Krista. Exogenous Liposomal ceramide-c6 ammeliorates lipidomic profile, energy homeostasis and anti-oxidant systems in NASH. _Cells_. 2020. Vol. 9, núm. 5. [consulta: 24 de gener de 2026]. ISSN: 2073-4409. [Disponible a: https://hdl.handle.net/2445/174879]

Exportar metadades

JSON - METS

Compartir registre